<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01252901</url>
  </required_header>
  <id_info>
    <org_study_id>WT1 Registry</org_study_id>
    <nct_id>NCT01252901</nct_id>
  </id_info>
  <brief_title>Registry for Patients With Wilms' Tumor Suppressor Gene 1 (WT1) Mutation Associated Diseases</brief_title>
  <official_title>Registry for Patients With WT1 Mutation Associated Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Wilms' tumor suppressor gene 1 (WT1) encodes for a transcription factor which plays an
      important role during urogenital development. Patients carrying a WT1 germline mutation show
      symptoms like proteinuria, Wilms tumors, genital malformations and kidney failure. Milder
      variants are possible and classification is not always possible. In this registry we are
      collecting detailed clinical data of affected individuals to establish genotype-phenotype
      correlations with the greater goal to optimize patient care.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Wilms' tumor suppressor gene 1 (WT1) encodes for a transcription factor which plays an
      important role during urogenital development. Patients carrying a WT1 germline mutation show
      symptoms like proteinuria, Wilms tumors, genital malformations and kidney failure, which
      usually occur in early childhood. Milder variants are possible and classification as one of
      the three rare syndromes associated with WT1 mutations (Denys-Drash syndrome, Frasier
      syndrome or WAGR syndrome) is not always possible. In this registry we are collecting
      detailed clinical data of affected individuals to establish genotype-phenotype correlations
      with the greater goal to optimize patient care.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">52</enrollment>
  <condition>Denys-Drash Syndrome</condition>
  <condition>Frasier Syndrome</condition>
  <condition>Nephrotic Syndrome</condition>
  <condition>Wilms Tumor</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with WT1 mutation
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Germline mutation in WT1 gene

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anja Lehnhardt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsklinikum Hamburg-Eppendorf</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universitätskrankenhaus Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.uke.de</url>
    <description>University Medical Center Hamburg-Eppendorf</description>
  </link>
  <link>
    <url>http://www.gp-nephrologie.de</url>
    <description>Gesellschaft für Pädiatrische Nephrologie</description>
  </link>
  <link>
    <url>http://www.netzwerk-is.de/</url>
    <description>DSD Network for Disorders of Sex Development</description>
  </link>
  <link>
    <url>http://www.kinderkrebsinfo.de</url>
    <description>Das Informationsportal der Gesellschaft für Pädiatrische Onkologie und Hämatologie</description>
  </link>
  <reference>
    <citation>Royer-Pokora B, Beier M, Henzler M, Alam R, Schumacher V, Weirich A, Huff V. Twenty-four new cases of WT1 germline mutations and review of the literature: genotype/phenotype correlations for Wilms tumor development. Am J Med Genet A. 2004 Jun 15;127A(3):249-57.</citation>
    <PMID>15150775</PMID>
  </reference>
  <reference>
    <citation>Mucha B, Ozaltin F, Hinkes BG, Hasselbacher K, Ruf RG, Schultheiss M, Hangan D, Hoskins BE, Everding AS, Bogdanovic R, Seeman T, Hoppe B, Hildebrandt F; Members of the APN Study Group. Mutations in the Wilms' tumor 1 gene cause isolated steroid resistant nephrotic syndrome and occur in exons 8 and 9. Pediatr Res. 2006 Feb;59(2):325-31.</citation>
    <PMID>16439601</PMID>
  </reference>
  <reference>
    <citation>Ruf RG, Schultheiss M, Lichtenberger A, Karle SM, Zalewski I, Mucha B, Everding AS, Neuhaus T, Patzer L, Plank C, Haas JP, Ozaltin F, Imm A, Fuchshuber A, Bakkaloglu A, Hildebrandt F; APN Study Group. Prevalence of WT1 mutations in a large cohort of patients with steroid-resistant and steroid-sensitive nephrotic syndrome. Kidney Int. 2004 Aug;66(2):564-70.</citation>
    <PMID>15253707</PMID>
  </reference>
  <reference>
    <citation>Kist-van Holthe JE, Ho PL, Stablein D, Harmon WE, Baum MA. Outcome of renal transplantation for Wilms' tumor and Denys-Drash syndrome: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant. 2005 Jun;9(3):305-10.</citation>
    <PMID>15910385</PMID>
  </reference>
  <reference>
    <citation>Aucella F, Bisceglia L, De Bonis P, Gigante M, Caridi G, Barbano G, Mattioli G, Perfumo F, Gesualdo L, Ghiggeri GM. WT1 mutations in nephrotic syndrome revisited. High prevalence in young girls, associations and renal phenotypes. Pediatr Nephrol. 2006 Oct;21(10):1393-8. Epub 2006 Aug 15.</citation>
    <PMID>16909243</PMID>
  </reference>
  <reference>
    <citation>Chesney RW. Why is the oncogene WT1 in the developing kidney and what is it doing there? Pediatr Nephrol. 2002 Dec;17(12):990-2. Epub 2002 Oct 1.</citation>
    <PMID>12520325</PMID>
  </reference>
  <reference>
    <citation>Klamt B, Koziell A, Poulat F, Wieacker P, Scambler P, Berta P, Gessler M. Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1 +/-KTS splice isoforms. Hum Mol Genet. 1998 Apr;7(4):709-14.</citation>
    <PMID>9499425</PMID>
  </reference>
  <reference>
    <citation>Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L, et al. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell. 1991 Oct 18;67(2):437-47.</citation>
    <PMID>1655284</PMID>
  </reference>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 1, 2010</study_first_submitted>
  <study_first_submitted_qc>December 2, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 3, 2010</study_first_posted>
  <last_update_submitted>May 27, 2015</last_update_submitted>
  <last_update_submitted_qc>May 27, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 28, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>WT1</keyword>
  <keyword>Wilms Tumor</keyword>
  <keyword>Denys-Drash Syndrome</keyword>
  <keyword>Nephrotic Syndrome</keyword>
  <keyword>Proteinuria</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Wilms Tumor</mesh_term>
    <mesh_term>Nephrotic Syndrome</mesh_term>
    <mesh_term>Nephrosis</mesh_term>
    <mesh_term>Denys-Drash Syndrome</mesh_term>
    <mesh_term>Frasier Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

